Cargando…
Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy
SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have made an indelible mark on metastatic colorectal cancer patients with microsatellite instability-high (MSI-H) instead of microsatellite stability (MSS) tumors. Clinical studies have explored the introduction of ICIs into treatment for locally a...
Autores principales: | Yin, Xin-Ke, Wang, Chao, Feng, Li-Li, Bai, Shao-Mei, Feng, Wei-Xing, Ouyang, Neng-Tai, Chu, Zhong-Hua, Fan, Xin-Juan, Qin, Qi-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688334/ https://www.ncbi.nlm.nih.gov/pubmed/36428666 http://dx.doi.org/10.3390/cancers14225573 |
Ejemplares similares
-
Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2020) -
Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications
por: Hav, Monirath, et al.
Publicado: (2015) -
Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
por: Matsutani, Shinji, et al.
Publicado: (2018) -
Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
por: Xu, Yao, et al.
Publicado: (2021) -
Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)